Seagen Inc.
Methods of inhibition of protein fucosylation in vivo using fucose analogs
Last updated:
Abstract:
The invention provides methods and compositions for the inhibition of fucosylation of proteins, including antibodies, in vivo by administration of a fucose analog.
Status:
Grant
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
15 Jun 2021